Harmony Biosciences
#4330
Rank
$1.96B
Marketcap
United States
Country
Mr. Jeffrey S. Aronin (Founder & Non-Exec. Chairman)
Mr. John Charles Jacobs M.B.A. (Pres, CEO & Director)
Mr. Sandip S. Kapadia CPA, M.B.A. (Exec. VP & CFO)
Summary
History
Harmony was founded in 2015 by industry veterans, who share a common vision of discovering, developing and delivering novel treatments to those living with CNS disorders. The company’s first product, WAKIX® (pitolisant), was approved by the U.S. Food and Drug Administration (FDA) in June 2019 for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adult patients with narcolepsy. Harmonys pipeline includes multiple product candidates in various stages of clinical development for the treatment of various CNS disorders.
Mission
Vision
Key Team
Dr. Jeffrey M. Dayno M.D. (Exec. VP & Chief Medical Officer)
Mr. Jeffrey Dierks M.B.A. (Exec. VP & Chief Commercial Officer)
Mr. Andrew Serafin J.D., M.B.A. (Exec. VP & Chief Strategy Officer)
Mr. David Bradshaw (Head of Technical Operations)
Ms. Sharon Goldbach (Head of Facilities Operations & Exec. Admin.)
Luis Sanay (Head of Investor Relations)
Mr. Christian Ulrich (Gen. Counsel)
Recognition and Awards
References
Mr. Jeffrey S. Aronin (Founder & Non-Exec. Chairman)
Mr. John Charles Jacobs M.B.A. (Pres, CEO & Director)
Mr. Sandip S. Kapadia CPA, M.B.A. (Exec. VP & CFO)